Medtech’s Mixed-up Monsters

October, 2018    SMM-186 Medtech’s Mixed-up Monsters If nature abhors a vacuum, traditional theory has it that investors hate conglomerates; markets tend to value aggregates of different businesses at less than the sum of their parts. How...